We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
+10.76%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$138B
AUM Growth
+$19.4B
(+16%)
Cap. Flow
+$7.6B
Cap. Flow
% of AUM
5.51%
Top 10 Holdings %
Top 10 Hldgs %
15.42%
Holding
4,486
New
399
Increased
2,092
Reduced
1,353
Closed
351
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.28B |
| 2 |
Microsoft
MSFT
|
+$517M |
| 3 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$351M |
| 4 |
Apple
AAPL
|
+$302M |
| 5 |
Wells Fargo
WFC
|
+$242M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$685M |
| 2 |
Vanguard Extended Market ETF
VXF
|
+$566M |
| 3 |
Entergy
ETR
|
+$367M |
| 4 |
CTXS
Citrix Systems Inc
CTXS
|
+$340M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$253M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.22% |
| 2 | Technology | 11.9% |
| 3 | Financials | 9.98% |
| 4 | Consumer Discretionary | 7.32% |
| 5 | Communication Services | 5.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3451
ANI Pharmaceuticals
ANIP
$1.8B
| $517K | ﹤0.01% |
8,372
+1,550
| +23% | +$103K |
|
3452
Marten Transport
MRTN
$1.21B
| $517K | ﹤0.01% |
36,090
-8,625
| -19% | -$123K |
|
3453
Peapack-Gladstone Financial
PGC
$815M
| $517K | ﹤0.01% |
16,749
-4,148
| -20% | -$122K |
|
|
FFIC
3454
DELISTED
Flushing Financial
FFIC
| $514K | ﹤0.01% |
23,816
-4,570
| -16% | -$97.2K |
|
|
NPKI
3455
NPK International
NPKI
$1.06B
| $514K | ﹤0.01% |
81,927
-5,882
| -7% | -$38.3K |
|
3456
Columbia Financial
CLBK
$1.12B
| $513K | ﹤0.01% |
30,311
-4,197
| -12% | -$69.3K |
|
|
HMHC
3457
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $513K | ﹤0.01% |
82,123
+3,597
| +5% | +$21K |
|
3458
TORM
TRMD
$3.1B
| $512K | ﹤0.01% |
47,270
+16,207
| +52% | +$154K |
|
3459
Ennis
EBF
$552M
| $511K | ﹤0.01% |
23,602
-2,520
| -10% | -$51.2K |
|
3460
Lindblad Expeditions
LIND
$1.94B
| $511K | ﹤0.01% |
31,269
-29,983
| -49% | -$479K |
|
3461
Harte-Hanks
HHS
$16.2M
| $510K | ﹤0.01% |
142,486
+12,200
| +9% | +$36.3K |
|
3462
Precigen
PGEN
$2.24B
| $510K | ﹤0.01% |
93,171
+24,038
| +35% | +$135K |
|
|
BMTC
3463
DELISTED
Bryn Mawr Bank Corp
BMTC
| $509K | ﹤0.01% |
12,358
-3,208
| -21% | -$124K |
|
3464
Cato Corp
CATO
$68.3M
| $508K | ﹤0.01% |
29,238
-505
| -2% | -$9.04K |
|
|
PDS
3465
Precision Drilling
PDS
$999M
| $508K | ﹤0.01% |
18,125
+694
| +4% | +$15.9K |
|
|
FSR
3466
DELISTED
Fisker Inc.
FSR
| $508K | ﹤0.01% |
+50,000
| New | +$504K |
|
3467
Bally's
BALY
$682M
| $507K | ﹤0.01% |
19,762
-3,569
| -15% | -$86K |
|
3468
VanEck India Growth Leaders ETF
GLIN
$96.2M
| $507K | ﹤0.01% |
15,462
-178,700
| -92% | -$5.78M |
|
3469
FB Financial Corp
FBK
$3.02B
| $506K | ﹤0.01% |
12,787
-2,509
| -16% | -$96.1K |
|
3470
Origin Bancorp
OBK
$1.69B
| $506K | ﹤0.01% |
13,376
-265
| -2% | -$9.29K |
|
|
ECC
3471
Eagle Point Credit Company
ECC
$512M
| $504K | ﹤0.01% |
+34,500
| New | +$525K |
|
3472
Tootsie Roll Industries
TR
$2.93B
| $503K | ﹤0.01% |
18,132
-4,452
| -20% | -$126K |
|
|
DCOM
3473
DELISTED
Dime Community Bancshares
DCOM
| $503K | ﹤0.01% |
24,107
-433
| -2% | -$8.88K |
|
|
IO
3474
DELISTED
ION Geophysical Corporation
IO
| $502K | ﹤0.01% |
+57,834
| New | +$500K |
|
3475
Atlanta Braves Holdings Series A
BATRA
$3.49B
| $499K | ﹤0.01% |
16,840
+2,338
| +16% | +$66.7K |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q4 2019 Portfolio in Review
As of Q4 2019, Credit Suisse held 4,486 positions worth $138B, up 16% from $119B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Credit Suisse deployed $7.6B of net new capital in Q4 2019, opening 399 new positions and adding to 2,092 existing holdings. Its largest new stake was iShares Russell 1000 Growth ETF: 1,727,952 shares worth $76M.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Vanguard Extended Market ETF, an estimated $566M trimmed.
- Credit Suisse's largest Q4 2019 buy was iShares Russell 1000 Growth ETF: 1,727,952 shares worth $76M.
- Credit Suisse added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $1.28B increase.
- Credit Suisse's biggest Q4 2019 reduction was Vanguard Extended Market ETF, cutting an estimated $566M.
- Credit Suisse fully exited Celgene Corp in Q4 2019, selling an estimated $685M.
- Credit Suisse's ten largest holdings make up 15% of its $138B portfolio in Q4 2019.
- Credit Suisse opened 399 new positions and closed 351 in Q4 2019.
- Credit Suisse's portfolio value rose 16% quarter-over-quarter to $138B.
Based on Credit Suisse's 13F filing for Q4 2019, filed 12 Feb 2020.